Canhelp Genomics

In a world facing a projected 26 million new cancer cases annually by 2030, the demand for innovative, accessible diagnostic solutions has never been more critical. The global precision diagnostics market is poised for explosive growth, reaching USD 50.3 billion by 2030 with a CAGR of 18.4% from 2024 onward. Canhelp Genomics is at the forefront of this transformation—a commercial-stage, China-ba...